XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balances at Dec. 31, 2019 $ 35,466 $ 5 $ 18 $ 447,965 $ (9,043) $ (405,504) $ 2,025
Beginning Balances (in shares) at Dec. 31, 2019   5,000,000 16,986,000        
Net loss (2,047)         (2,047)  
Unrealized loss from foreign currency translation adjustments (480)           (480)
Issuance of common stock in connection with vesting of stock awards (shares)     150,000        
Stock-based compensation 640     640      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (225)       (225)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (48,000)        
Issuance of common stock in connection with warrant exercise     $ 1 (1)      
Issuance of common stock in connection with warrant exercise (shares)     387,000        
Ending Balances at Mar. 31, 2020 33,354 $ 5 $ 19 448,604 (9,268) (407,551) 1,545
Ending Balances (in shares) at Mar. 31, 2020   5,000,000 17,475,000        
Beginning Balances at Dec. 31, 2020 34,189 $ 5 $ 19 452,129 (9,933) (410,609) 2,578
Beginning Balances (in shares) at Dec. 31, 2020   5,000,000 18,055,000        
Net loss (1,465)         (1,465)  
Unrealized loss from foreign currency translation adjustments (283)           (283)
Issuance of common stock in connection with vesting of stock awards (shares)     98,000        
Proceeds of exercise of stock options $ 34     34      
Proceed of exercise of stock options (shares) 5,254   5,000        
Stock-based compensation $ 758     758      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (253)       (253)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (25,000)        
Issuance of common stock in connection with warrant exercise (shares)     28,000        
Ending Balances at Mar. 31, 2021 $ 32,980 $ 5 $ 19 $ 452,921 $ (10,186) $ (412,074) $ 2,295
Ending Balances (in shares) at Mar. 31, 2021   5,000,000 18,161,000